Transcriptome-based Identification of Antioxidative Gene Expression After Fish Oil Supplementation in Normo- and Dyslipidemic Men

Overview

Journal Nutr Metab (Lond)

Publisher Biomed Central

Date 2012 May 25

PMID 22621246

Citations 23

Authors

Simone Schmidt

Frank Stahl

Kai-Oliver Mutz

Thomas Scheper

Andreas Hahn

Jan Philipp Schuchardt

Affiliations

Soon will be listed here.

Abstract

Background: The beneficial effects of omega-3 polyunsaturated fatty acids (n-3 PUFAs), especially in dyslipidemic subjects with a high risk of cardiovascular disease, are widely described in the literature. A lot of effects of n-3 PUFAs and their oxidized metabolites are triggered by regulating the expression of genes. Currently, it is uncertain if the administration of n-3 PUFAs results in different expression changes of genes related to antioxidative mechanisms in normo- and dyslipidemic subjects, which may partly explain their cardioprotective effects. The aim of this study was to investigate the effects of n-3 PUFA supplementation on expression changes of genes involved in oxidative processes.

Methods: Ten normo- and ten dyslipidemic men were supplemented for twelve weeks with fish oil capsules, providing 1.14 g docosahexaenoic acid and 1.56 g eicosapentaenoic acid. Gene expression levels were determined by whole genome microarray analysis and quantitative real-time polymerase chain reaction (qRT-PCR).

Results: Using microarrays, we discovered an increased expression of antioxidative enzymes and a decreased expression of pro-oxidative and tissue enzymes, such as cytochrome P450 enzymes and matrix metalloproteinases, in both normo- and dyslipidemic men. An up-regulation of catalase and heme oxigenase 2 in both normo- and dyslipidemic subjects and an up-regulation of cytochrome P450 enzyme 1A2 only in dyslipidemic subjects could be observed by qRT-PCR analysis.

Conclusions: Supplementation of normo- and dyslipidemic subjects with n-3 PUFAs changed the expression of genes related to oxidative processes, which may suggest antioxidative and potential cardioprotective effects of n-3 PUFAs. Further studies combining genetic and metabolic endpoints are needed to verify the regulative effects of n-3 PUFAs in antioxidative gene expression to better understand their beneficial effects in health and disease prevention.

Trial Registration: ClinicalTrials.gov (ID: NCT01089231).

Citing Articles

Identification of Optimal Reference Genes for qRT-PCR Normalization for Physical Activity Intervention and Omega-3 Fatty Acids Supplementation in Humans.

Grzybkowska A, Anczykowska K, Antosiewicz J, Olszewski S, Dzitkowska-Zabielska M, Tomczyk M Int J Mol Sci. 2023; 24(7).

PMID: 37047706 PMC: 10094777. DOI: 10.3390/ijms24076734.

Fish Oil - Omega-3 Exerts Protective Effect in Oxidative Stress and Liver Dysfunctions Resulting from Experimental Sepsis.

Velasque M, Branchini G, Catarina A, Bettoni L, Fernandes R, da Silva A J Clin Exp Hepatol. 2023; 13(1):64-74.

PMID: 36647406 PMC: 9840085. DOI: 10.1016/j.jceh.2022.07.001.

Lung Surfactant Accelerates Skin Wound Healing: A Translational Study with a Randomized Clinical Phase I Study.

Mirastschijski U, Schwab I, Coger V, Zier U, Rianna C, He W Sci Rep. 2020; 10(1):2581.

PMID: 32054903 PMC: 7018835. DOI: 10.1038/s41598-020-59394-5.

Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine.

Antonini R, Scaini G, Michels M, Matias M, Schuck P, Ferreira G Metab Brain Dis. 2019; 35(2):295-303.

PMID: 31828693 DOI: 10.1007/s11011-019-00525-x.

Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation.

Yang J, Fernandez-Galilea M, Martinez-Fernandez L, Gonzalez-Muniesa P, Perez-Chavez A, Martinez J Nutrients. 2019; 11(4).

PMID: 31003450 PMC: 6521137. DOI: 10.3390/nu11040872.

References

Wu G, Fang Y, Yang S, Lupton J, Turner N . Glutathione metabolism and its implications for health. J Nutr. 2004; 134(3):489-92. DOI: 10.1093/jn/134.3.489. View

Mueller S, Riedel H, Stremmel W . Direct evidence for catalase as the predominant H2O2 -removing enzyme in human erythrocytes. Blood. 1998; 90(12):4973-8. View

Shiomi T, Lemaitre V, DArmiento J, Okada Y . Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int. 2010; 60(7):477-96. PMC: 3745773. DOI: 10.1111/j.1440-1827.2010.02547.x. View

Filaire E, Massart A, Portier H, Rouveix M, Rosado F, Bage A . Effect of 6 Weeks of n-3 fatty-acid supplementation on oxidative stress in Judo athletes. Int J Sport Nutr Exerc Metab. 2010; 20(6):496-506. DOI: 10.1123/ijsnem.20.6.496. View

Kim H, Lee Y, Eun H, Chung J . Eicosapentaenoic acid inhibits TNF-alpha-induced matrix metalloproteinase-9 expression in human keratinocytes, HaCaT cells. Biochem Biophys Res Commun. 2008; 368(2):343-9. DOI: 10.1016/j.bbrc.2008.01.062. View

Skulas-Ray A, West S, Davidson M, Kris-Etherton P . Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Expert Opin Pharmacother. 2008; 9(7):1237-48. DOI: 10.1517/14656566.9.7.1237. View

Rajeevan M, Vernon S, Taysavang N, Unger E . Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn. 2001; 3(1):26-31. PMC: 1907344. DOI: 10.1016/S1525-1578(10)60646-0. View

Harris W, von Schacky C . The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med. 2004; 39(1):212-20. DOI: 10.1016/j.ypmed.2004.02.030. View

Olivieri O, Negri M, De Gironcoli M, Bassi A, Guarini P, Stanzial A . Effects of dietary fish oil on malondialdehyde production and glutathione peroxidase activity in hyperlipidaemic patients. Scand J Clin Lab Invest. 1988; 48(7):659-65. View

10.

Mabile L, Piolot A, Boulet L, Fortin L, Doyle N, Rodriguez C . Moderate intake of n-3 fatty acids is associated with stable erythrocyte resistance to oxidative stress in hypertriglyceridemic subjects. Am J Clin Nutr. 2001; 74(4):449-56. DOI: 10.1093/ajcn/74.4.449. View

11.

Ye D, Zhang D, Oltman C, Dellsperger K, Lee H, VanRollins M . Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J Pharmacol Exp Ther. 2002; 303(2):768-76. DOI: 10.1124/jpet.303.2.768. View

12.

Salkoff L, Butler A, Ferreira G, Santi C, Wei A . High-conductance potassium channels of the SLO family. Nat Rev Neurosci. 2006; 7(12):921-31. DOI: 10.1038/nrn1992. View

13.

Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A . Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002; 3(7):RESEARCH0034. PMC: 126239. DOI: 10.1186/gb-2002-3-7-research0034. View

14.

Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F . Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta. 2001; 303(1-2):33-9. DOI: 10.1016/s0009-8981(00)00358-2. View

15.

Kronke G, Kadl A, Ikonomu E, Bluml S, Furnkranz A, Sarembock I . Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol. 2007; 27(6):1276-82. DOI: 10.1161/ATVBAHA.107.142638. View

16.

Arnold C, Konkel A, Fischer R, Schunck W . Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids. Pharmacol Rep. 2010; 62(3):536-47. DOI: 10.1016/s1734-1140(10)70311-x. View

17.

Spinale F, Coker M, Heung L, Bond B, Gunasinghe H, Etoh T . A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. 2000; 102(16):1944-9. DOI: 10.1161/01.cir.102.16.1944. View

18.

Harris W . n-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids. 1996; 31(3):243-52. DOI: 10.1007/BF02529870. View

19.

Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

20.

Tremoli E, Eligini S, Colli S, Maderna P, Rise P, Pazzucconi F . n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes. Arterioscler Thromb. 1994; 14(10):1600-8. DOI: 10.1161/01.atv.14.10.1600. View